NextPoint Therapeutics, Inc.

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

• Detlev Biniszkiewicz — Director, Cambridge, MA
• Ivan Cheung — Executive Officer / Director, Cambridge, MA
• Axel Hoos — Director, Cambridge, MA
• R. Jacob Vogelstein — Director, Cambridge, MA
  15 other raises

  • Catalio Access Fund XII, LLC $20.1M of $20.1M · 100.0%
  • Catalio Access Fund XI, LLC $16.3M of $16.3M · 100.0%
  • Catalio Access Fund IX, LLC $17.3M of $17.3M · 100.0%
  • Catalio Inflection Fund III, LLC $8.0M of $8.0M · 100.0%
  • Catalio Inflection Fund II, LLC $10.0M of $10.0M · 100.0%
  • Catalio Structured Opportunities Offshore Fund II, LP $122.8M of —
  • Catalio Structured Opportunities Fund II, LP $179.3M of —
  • Catalio Genesis Fund X, LLC $19.1M of $19.1M · 100.0%
  • Catalio Access Fund X, LLC $20.3M of $20.3M · 100.0%
  • Catalio Access Fund VIII, LLC $25.0M of $25.0M · 100.0%
  • Catalio Public Equities Offshore Fund, Ltd. $142.1M of —
  • Catalio Public Equities Fund, LP $83.9M of —
  • Catalio Nexus Fund IV, LP $357.6M of —
  • Iambic Therapeutics, Inc. $99.3M of $125.0M · 79.4%
  • Catalio Genesis Fund IX, LLC $8.6M of $8.6M · 100.0%
• Brian Shuster — Director, Cambridge, MA
  1 other raise

  • RWA Flood, Inc. $143K of $1.2M · 11.9%
• Paulina Hill — Director, Cambridge, MA
  1 other raise

  • Odyssey Therapeutics, Inc. $214.0M of $214.0M · 100.0%
• Rakhshita Dhar — Director, Cambridge, MA
  2 other raises

  • SonoThera, Inc. $125.5M of $125.5M · 100.0%
  • RECODE THERAPEUTICS, INC. $29.4M of $29.4M · 100.0%
• Jeffrey Lacey — Executive Officer, Cambridge, MA

Placement agents

• No sales compensation reported — direct raise.